» Articles » PMID: 29540734

A Lachnospiraceae-dominated Bacterial Signature in the Fecal Microbiota of HIV-infected Individuals from Colombia, South America

Abstract

HIV infection has a tremendous impact on the immune system's proper functioning. The mucosa-associated lymphoid tissue (MALT) is significantly disarrayed during HIV infection. Compositional changes in the gut microbiota might contribute to the mucosal barrier disruption, and consequently to microbial translocation. We performed an observational, cross-sectional study aimed at evaluating changes in the fecal microbiota of HIV-infected individuals from Colombia. We analyzed the fecal microbiota of 37 individuals via 16S rRNA gene sequencing; 25 HIV-infected patients and 12 control (non-infected) individuals, which were similar in body mass index, age, gender balance and socioeconomic status. To the best of our knowledge, no such studies have been conducted in Latin American countries. Given its compositional nature, microbiota data were normalized and transformed using Aitchison's Centered Log-Ratio. Overall, a change in the network structure in HIV-infected patients was revealed by using the SPIEC-EASI MB tool. Genera such as Blautia, Dorea, Yersinia, Escherichia-Shigella complex, Staphylococcus, and Bacteroides were highly relevant in HIV-infected individuals. Differential abundance analysis by both sparse Partial Least Square-Discriminant Analysis and Random Forest identified a greater abundance of Lachnospiraceae-OTU69, Blautia, Dorea, Roseburia, and Erysipelotrichaceae in HIV-infected individuals. We show here, for the first time, a predominantly Lachnospiraceae-based signature in HIV-infected individuals.

Citing Articles

Undernutrition disrupts jejunal and ileal microbiota and epithelial tissue homeostasis in a pregnant sheep model.

Wu W, Akhtar M, Geng J, Lu H, Rahim M, Cheng J Anim Nutr. 2025; 20:263-276.

PMID: 39995522 PMC: 11847739. DOI: 10.1016/j.aninu.2024.10.004.


HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis.

Hu A, Zaongo S, Harypursat V, Wang X, Ouyang J, Chen Y Front Microbiol. 2024; 15:1428239.

PMID: 39155987 PMC: 11327151. DOI: 10.3389/fmicb.2024.1428239.


Alterations in the Gut Microbiome Composition of People Living with HIV in the Asia-Pacific Region: A Systematic Review.

Salvador P, Altavas P, Del Rosario M, Ornos E, Dalmacio L Clin Pract. 2024; 14(3):846-861.

PMID: 38804398 PMC: 11130874. DOI: 10.3390/clinpract14030066.


A Two-Faced Gut Microbiome: Butyrogenic and Proinflammatory Bacteria Predominate in the Intestinal Milieu of People Living with HIV from Western Mexico.

Baltazar-Diaz T, Andrade-Villanueva J, Sanchez-Alvarez P, Amador-Lara F, Holguin-Aguirre T, Sanchez-Reyes K Int J Mol Sci. 2024; 25(9).

PMID: 38732048 PMC: 11084381. DOI: 10.3390/ijms25094830.


Dysbiosis of gut microbiota and metabolites during AIDS: implications for CD4 + T cell reduction and immune activation.

Zhou J, Yang Y, Xie Z, Lu D, Huang J, Lan L AIDS. 2023; 38(5):633-644.

PMID: 38061029 PMC: 10942204. DOI: 10.1097/QAD.0000000000003812.


References
1.
Vujkovic-Cvijin I, Dunham R, Iwai S, Maher M, Albright R, Broadhurst M . Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med. 2013; 5(193):193ra91. PMC: 4094294. DOI: 10.1126/scitranslmed.3006438. View

2.
Chevalier M, Weiss L . The split personality of regulatory T cells in HIV infection. Blood. 2012; 121(1):29-37. DOI: 10.1182/blood-2012-07-409755. View

3.
Christensen-Quick A, Lafferty M, Sun L, Marchionni L, DeVico A, Garzino-Demo A . Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection. J Virol. 2016; 90(17):7833-47. PMC: 4988157. DOI: 10.1128/JVI.02869-15. View

4.
Brenchley J, Douek D . HIV infection and the gastrointestinal immune system. Mucosal Immunol. 2008; 1(1):23-30. PMC: 2777614. DOI: 10.1038/mi.2007.1. View

5.
Pinto-Cardoso S, Klatt N, Reyes-Teran G . Impact of antiretroviral drugs on the microbiome: unknown answers to important questions. Curr Opin HIV AIDS. 2017; 13(1):53-60. PMC: 5718259. DOI: 10.1097/COH.0000000000000428. View